Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) EBT Margin (2024 - 2025)

Historic EBT Margin for Pyxis Oncology (PYXS) over the last 2 years, with Q2 2025 value amounting to 640.82%.

  • Pyxis Oncology's EBT Margin changed N/A to 640.82% in Q2 2025 from the same period last year, while for Sep 2025 it was 3527.73%, marking a year-over-year change of. This contributed to the annual value of 492.35% for FY2024, which is N/A changed from last year.
  • As of Q2 2025, Pyxis Oncology's EBT Margin stood at 640.82%.
  • In the past 5 years, Pyxis Oncology's EBT Margin ranged from a high of 24.8% in Q1 2024 and a low of 640.82% during Q2 2025